Health officials said the risk to the general public is low and said most individuals are protected through routine childhood ...
The replication of the Nipah virus's genetic material in infected cells has been demonstrated for the first time by ...
NanoViricides, Inc. (the “Company”)(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its ...